Poland· PL-100537091
Prepidil
A dinoprostone product containing dinoprostonum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dinoprostone is registered in 14 of 19 countries.
Countries holding a registration under ATC G02AD02 (dinoprostone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Dinoprostone · ATC G02AD02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Dinoprostonum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G02AD02
- ATC class
- Dinoprostone
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991599539
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dinoprostone in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsPrepidil 0,5 mg/3 g, gel voor endocervicaal gebruikPfizer B.V.
- United KingdomDinoprostone 10mg vaginal deviceFerring Pharmaceuticals Ltd
- BelgiumPrepidil 0.5 mg - 3 gPfizer
- FinlandMinprostinPfizer Oy
- CanadaCERVIDILFERRING INC
- FrancePREPIDIL INTRACERVICAL, gel stérile intracervicalPFIZER HOLDING FRANCE
- IrelandPropess 10 mg vaginal delivery systemFerring Ireland Ltd
- GermanyMinprostin E2Pfizer Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Prepidil, Propess
- Belgium · Prepidil, Propess
- Bulgaria · Пропес
- Cyprus · Propess, Prostin E2
- Czechia · Cervidil, Prostin E2
- Germany · Minprostin E2, Prepidil Gel
- Denmark · Propess
- Estonia · Propess
- Spain · Propess, Prostaglandina E2 Pfizer
- Finland · Propess
- France · Prepidil Intracervical, Propess
- United Kingdom (Northern Ireland) · Propess, Prostin E2
- Greece · Propess, Prostin E2
- Croatia · Prepidil, Propess
- Hungary · Prepidil, Prostin E2
- Ireland · Propess, Prostin E2
- Italy · Prepidil, Propess
- Lithuania · Propess
- Luxembourg · Prepidil, Propess
- Latvia · Propess
- Malta · Prostin E2
- Netherlands · Prepidil, Propess
- Norway · Propess
- Portugal · Propess, Prostin E2
- Romania · Propess
- Sweden · Minprostin, Propess
- Slovenia · Propess
- Slovakia · Cervidil, Prepidil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a8158c9-3108-4f12-b4b2-e9fd0d1e63f2 GET /v1/drugs/2a8158c9-3108-4f12-b4b2-e9fd0d1e63f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel do szyjki macicy",
"source": "urpl",
"strength": "0,5 mg/3 g",
"packaging": "05909991599539 ¦ Lz ¦ 166807\n1 strzykawka 3 g",
"substance": "Dinoprostonum 0,5 mg/3 g",
"common_name": "Dinoprostonum",
"pl_product_id": "100537091",
"pozwolenie_nr": "146/26",
"auth_procedure": "IR",
"authorisation_validity": "2031-04-22"
}See everything about dinoprostone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.